Volume 16 Issue 1 - Winter 2024
Semaglutide Shows Promise as a Potential Alcohol Use Disorder Medication
Intramural scientists at the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA), and collaborators from The Scripps Research Institute, found that semaglutide reduces alcohol consumption and binge-like drinking in a rodent model of alcohol misuse. Published in the June 2023 issue of the journal JCI Insight, the study adds to growing preclinical evidence that the glucagon-like peptide-1 (GLP-1) system plays a role in alcohol and other substance use disorders, and that GLP-1 receptor agonists show potential for treating people with alcohol
Canadian Official Visits Clinical Center, Learns About Alcohol Research
The Honorable Ya’ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health for Canada (left), toured the National Institutes of Health Clinical Center on Nov. 13, 2023.
National Institute on Alcohol Abuse and Alcoholism Signs Letter of Intent With French Science Agency
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) has signed a letter of intent (LOI) with its French counterpart, Institut national de la santé et de la recherche médicale (National Institute of Health and Medical Research), also known as Inserm.
National Institute on Alcohol Abuse and Alcoholism Releases Web Resource for Middle School
Underage drinking is a significant public health problem in the United States. As part of its efforts to raise awareness of and combat underage drinking, the National Institute on Alcohol Abuse and Alcoholism (NIAAA) has launched NIAAA for Middle School. NIAAA for Middle School is an online resource that helps parents, caregivers, and teachers introduce and reinforce key messages about peer pressure and skills for resisting it, as well as about other important topics related to underage drinking.